| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |